tiprankstipranks
Trending News
More News >
Advertisement

ALIL - AI Analysis

Compare

Top Page

ALIL

Argent Focused Small Cap ETF (ALIL)

Rating:71Outperform
Price Target:
$32.00
The Argent Focused Small Cap ETF (ALIL) achieves a solid overall rating, driven by strong contributions from holdings like Addus Homecare (ADUS) and Medpace Holdings (MEDP). Addus Homecare stands out for its strategic acquisitions and stable valuation, while Medpace benefits from robust revenue growth and improved guidance, despite valuation concerns. However, weaker technical indicators and high leverage in holdings like Colliers International Group (CIGI) and OneMain Holdings (OMF) may have slightly tempered the fund’s overall score. Investors should also note potential risks from sector concentration in small-cap stocks, which can be more volatile.
Positive Factors
Strong Top Holdings
Several top holdings, like Medpace Holdings and RBC Bearings, have delivered strong year-to-date performance, supporting the ETF’s overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Financials, Industrials, and Technology, reducing reliance on any single industry.
Healthy Year-to-Date Performance
The ETF has shown positive year-to-date returns, indicating steady growth despite short-term fluctuations.
Negative Factors
High Expense Ratio
The ETF charges a relatively high expense ratio compared to many other funds, which can eat into investor returns over time.
Over-Concentration in U.S. Market
With over 99% exposure to U.S. companies, the fund lacks geographic diversification and is vulnerable to domestic market risks.
Mixed Performance Among Holdings
Some holdings, like Addus Homecare, have underperformed year-to-date, potentially dragging on overall fund performance.

ALIL vs. SPDR S&P 500 ETF (SPY)

ALIL Summary

The Argent Focused Small Cap ETF (ALIL) is an actively managed fund that invests in small-cap U.S. companies, aiming to outperform the Russell 2000 Index. It includes businesses across various sectors, such as Medpace Holdings and Houlihan Lokey, which are leaders in healthcare and financial services, respectively. This ETF is ideal for investors looking to diversify into smaller, potentially high-growth companies that are often overlooked in larger funds. However, since it focuses on small-cap stocks, it can be more volatile and sensitive to market fluctuations compared to funds with larger companies.
How much will it cost me?The Argent Focused Small Cap ETF (ALIL) has an expense ratio of 0.74%, which means you’ll pay $7.40 per year for every $1,000 invested. This is higher than average because the fund is actively managed, requiring more research and oversight compared to passively managed ETFs that track an index.
What would affect this ETF?The Argent Focused Small Cap ETF (ALIL) could benefit from a strong U.S. economy, as its focus on small-cap stocks and sectors like technology, financials, and consumer cyclical often thrive during periods of economic growth and innovation. However, rising interest rates or economic slowdowns could negatively impact small-cap companies, which tend to have higher debt levels and are more sensitive to changes in borrowing costs. Additionally, sector-specific challenges, such as regulatory changes in healthcare or real estate, could also affect the fund's performance.

ALIL Top 10 Holdings

The Argent Focused Small Cap ETF (ALIL) leans heavily into U.S. small-cap stocks, with notable exposure to financials, industrials, and technology. Medpace Holdings is a rising star, buoyed by strong revenue growth and bullish sentiment, while Addus Homecare shows steady progress despite challenges in its Home Health segment. On the flip side, Houlihan Lokey and OneMain Holdings are lagging, weighed down by weak momentum and mixed technical indicators. With a diverse mix of sectors and a focus on active management, the fund aims to uncover hidden gems in the dynamic small-cap space.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Houlihan Lokey4.31%$798.08K$14.21B21.23%
71
Outperform
Medpace Holdings4.28%$792.72K$16.35B76.05%
79
Outperform
Colliers International Group4.14%$765.34K$8.38B7.23%
68
Neutral
OneMain Holdings3.98%$736.14K$6.88B21.88%
71
Outperform
Victory Capital Holdings3.73%$689.57K$4.24B3.63%
76
Outperform
RBC Bearings3.68%$680.75K$12.88B42.79%
78
Outperform
Addus Homecare3.63%$672.40K$2.22B-7.13%
81
Outperform
Eplus3.46%$640.10K$1.97B-24.42%
71
Outperform
Green Brick Partners3.44%$636.33K$2.91B-11.46%
74
Outperform
Enpro3.42%$633.04K$4.76B51.51%
70
Outperform

ALIL Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
29.29
Negative
100DMA
28.94
Positive
200DMA
Market Momentum
MACD
0.02
Negative
RSI
53.62
Neutral
STOCH
90.59
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ALIL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.82, equal to the 50-day MA of 29.29, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 53.62 is Neutral, neither overbought nor oversold. The STOCH value of 90.59 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ALIL.

ALIL Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$18.54M0.74%
71
Outperform
$59.80M0.64%
66
Neutral
$55.25M0.36%
64
Neutral
$45.97M0.75%
70
Outperform
$31.37M0.89%
60
Neutral
$22.56M0.80%
66
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ALIL
Argent Focused Small Cap ETF
29.24
2.98
11.35%
OASC
OneAscent Small Cap Core ETF
FSCC
Federated Hermes MDT Small Cap Core ETF
AFSM
First Trust Active Factor Small Cap ETF
RFLR
Innovator U.S. Small Cap Managed Floor ETF
SMLL
Harbor Active Small Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement